Market Analysis and Insights: Global Pharma-Grade Hyaluronic Acid Market
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Hyaluronic Acid is generally used in pharmaceutical formulations, such as auxiliary agents for eye surgery and therapeutic agents for osteoarthritis of the knee joint.
Due to the COVID-19 pandemic, the global Pharma-Grade Hyaluronic Acid market size is estimated to be worth US$ 150.3 million in 2022 and is forecast to a readjusted size of US$ 276.7 million by 2028 with a CAGR of 10.7% during the review period. Fully considering the economic change by this health crisis, Injection Grade Hyaluronic Acid accounting for % of the Pharma-Grade Hyaluronic Acid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Auxiliary Agents for Eye Surgery segment is altered to an % CAGR throughout this forecast period.
Global pharma-grade hyaluronic acid includes Bloomage BioTechnology, AWA Biopharm, etc. Global top 3 companies hold a share about 70%.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Injection Grade Hyaluronic Acid
Eye Drops Grade Hyaluronic Acid
Segment by Application
Auxiliary Agents for Eye Surgery
Therapeutic Agents
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Pharma-Grade Hyaluronic Acid market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bloomage BioTechnology
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
1 Study Coverage
1.1 Pharma-Grade Hyaluronic Acid Product Introduction
1.2 Market by Type
1.2.1 Global Pharma-Grade Hyaluronic Acid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection Grade Hyaluronic Acid
1.2.3 Eye Drops Grade Hyaluronic Acid
1.3 Market by Application
1.3.1 Global Pharma-Grade Hyaluronic Acid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Auxiliary Agents for Eye Surgery
1.3.3 Therapeutic Agents
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharma-Grade Hyaluronic Acid Sales Estimates and Forecasts 2017-2028
2.2 Global Pharma-Grade Hyaluronic Acid Revenue Estimates and Forecasts 2017-2028
2.3 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pharma-Grade Hyaluronic Acid Sales by Region
2.4.1 Global Pharma-Grade Hyaluronic Acid Sales by Region (2017-2022)
2.4.2 Global Sales Pharma-Grade Hyaluronic Acid by Region (2023-2028)
2.5 Global Pharma-Grade Hyaluronic Acid Revenue by Region
2.5.1 Global Pharma-Grade Hyaluronic Acid Revenue by Region (2017-2022)
2.5.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pharma-Grade Hyaluronic Acid Sales by Manufacturers
3.1.1 Global Top Pharma-Grade Hyaluronic Acid Manufacturers by Sales (2017-2022)
3.1.2 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma-Grade Hyaluronic Acid in 2021
3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturers
3.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturers (2017-2022)
3.2.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pharma-Grade Hyaluronic Acid Revenue in 2021
3.3 Global Pharma-Grade Hyaluronic Acid Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pharma-Grade Hyaluronic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pharma-Grade Hyaluronic Acid Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharma-Grade Hyaluronic Acid Sales by Type
4.1.1 Global Pharma-Grade Hyaluronic Acid Historical Sales by Type (2017-2022)
4.1.2 Global Pharma-Grade Hyaluronic Acid Forecasted Sales by Type (2023-2028)
4.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2017-2028)
4.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type
4.2.1 Global Pharma-Grade Hyaluronic Acid Historical Revenue by Type (2017-2022)
4.2.2 Global Pharma-Grade Hyaluronic Acid Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2017-2028)
4.3 Global Pharma-Grade Hyaluronic Acid Price by Type
4.3.1 Global Pharma-Grade Hyaluronic Acid Price by Type (2017-2022)
4.3.2 Global Pharma-Grade Hyaluronic Acid Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pharma-Grade Hyaluronic Acid Sales by Application
5.1.1 Global Pharma-Grade Hyaluronic Acid Historical Sales by Application (2017-2022)
5.1.2 Global Pharma-Grade Hyaluronic Acid Forecasted Sales by Application (2023-2028)
5.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2017-2028)
5.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application
5.2.1 Global Pharma-Grade Hyaluronic Acid Historical Revenue by Application (2017-2022)
5.2.2 Global Pharma-Grade Hyaluronic Acid Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2017-2028)
5.3 Global Pharma-Grade Hyaluronic Acid Price by Application
5.3.1 Global Pharma-Grade Hyaluronic Acid Price by Application (2017-2022)
5.3.2 Global Pharma-Grade Hyaluronic Acid Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pharma-Grade Hyaluronic Acid Market Size by Type
6.1.1 North America Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)
6.1.2 North America Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)
6.2 North America Pharma-Grade Hyaluronic Acid Market Size by Application
6.2.1 North America Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)
6.2.2 North America Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)
6.3 North America Pharma-Grade Hyaluronic Acid Market Size by Country
6.3.1 North America Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)
6.3.2 North America Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pharma-Grade Hyaluronic Acid Market Size by Type
7.1.1 Europe Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)
7.1.2 Europe Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)
7.2 Europe Pharma-Grade Hyaluronic Acid Market Size by Application
7.2.1 Europe Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)
7.2.2 Europe Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)
7.3 Europe Pharma-Grade Hyaluronic Acid Market Size by Country
7.3.1 Europe Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)
7.3.2 Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Type
8.1.1 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)
8.1.2 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)
8.2 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Application
8.2.1 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)
8.2.2 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)
8.3 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Region
8.3.1 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (2017-2028)
8.3.2 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pharma-Grade Hyaluronic Acid Market Size by Type
9.1.1 Latin America Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)
9.1.2 Latin America Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)
9.2 Latin America Pharma-Grade Hyaluronic Acid Market Size by Application
9.2.1 Latin America Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)
9.2.2 Latin America Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)
9.3 Latin America Pharma-Grade Hyaluronic Acid Market Size by Country
9.3.1 Latin America Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)
9.3.2 Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Type
10.1.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Type (2017-2028)
10.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Application
10.2.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Application (2017-2028)
10.3 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Country
10.3.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bloomage BioTechnology
11.1.1 Bloomage BioTechnology Corporation Information
11.1.2 Bloomage BioTechnology Overview
11.1.3 Bloomage BioTechnology Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bloomage BioTechnology Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bloomage BioTechnology Recent Developments
11.2 AWA Biopharm
11.2.1 AWA Biopharm Corporation Information
11.2.2 AWA Biopharm Overview
11.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AWA Biopharm Recent Developments
11.3 Kewpie
11.3.1 Kewpie Corporation Information
11.3.2 Kewpie Overview
11.3.3 Kewpie Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Kewpie Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Kewpie Recent Developments
11.4 Contipro
11.4.1 Contipro Corporation Information
11.4.2 Contipro Overview
11.4.3 Contipro Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Contipro Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Contipro Recent Developments
11.5 Seikagaku
11.5.1 Seikagaku Corporation Information
11.5.2 Seikagaku Overview
11.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Seikagaku Recent Developments
11.6 HTL Biotechnology
11.6.1 HTL Biotechnology Corporation Information
11.6.2 HTL Biotechnology Overview
11.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HTL Biotechnology Recent Developments
11.7 Fidia Farmaceutici
11.7.1 Fidia Farmaceutici Corporation Information
11.7.2 Fidia Farmaceutici Overview
11.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fidia Farmaceutici Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharma-Grade Hyaluronic Acid Industry Chain Analysis
12.2 Pharma-Grade Hyaluronic Acid Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharma-Grade Hyaluronic Acid Production Mode & Process
12.4 Pharma-Grade Hyaluronic Acid Sales and Marketing
12.4.1 Pharma-Grade Hyaluronic Acid Sales Channels
12.4.2 Pharma-Grade Hyaluronic Acid Distributors
12.5 Pharma-Grade Hyaluronic Acid Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pharma-Grade Hyaluronic Acid Industry Trends
13.2 Pharma-Grade Hyaluronic Acid Market Drivers
13.3 Pharma-Grade Hyaluronic Acid Market Challenges
13.4 Pharma-Grade Hyaluronic Acid Market Restraints
14 Key Findings in The Global Pharma-Grade Hyaluronic Acid Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer